Unique Ingredient Identifier 3980JIH2SW is listed as a unspecified ingredient
| NCIT | C66549 |
| RXCUI | 235496 |
UNII 3980JIH2SW SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | FILM | 0.47 MG |
| BUCCAL | FILM, SOLUBLE | 0.76 MG |
| IM - IV | INJECTABLE | 0.16 % |
| IM - IV | INJECTION | 1.47 % |
| INTRALESIONAL | SUSPENSION, INJECTION | 0.68 % |
| INTRAMUSCULAR | INJECTION | 2.56 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.18 %W/V |
| INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 0.6 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.68 %W/V |
| INTRASYNOVIAL | SUSPENSION, INJECTION | 0.68 % |
| INTRAVENOUS | INJECTION | 2.56 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.18 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.35 % |
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 14.2 MG |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 1.32 % |
| OPHTHALMIC | SOLUTION | 0.19 % |
| ORAL | SOLUTION | 25 MG/5ML |
| ORAL | SOLUTION, LIQUID | ADJPH |
| ORAL | SUSPENSION | 32.5 MG/5ML |
| ORAL | TABLET | 1.38 MG |
| SOFT TISSUE | SUSPENSION, INJECTION | 0.68 % |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.022 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.11 % |
| TOPICAL | CREAM, AUGMENTED | 0.2 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.27 %W/W |
| TOPICAL | EMULSION, CREAM | 0.27 %W/W |
| TOPICAL | LOTION | 0.3 %W/W |
| TOPICAL | LOTION, AUGMENTED | 0.2 %W/W |
| TOPICAL | PATCH, CONTROLLED RELEASE | 14.2 MG |
| TOPICAL | SHAMPOO, SUSPENSION | NA |
| TOPICAL | SOLUTION | 0.1 %W/V |